The FDA has approved a first-of-its-kind treatment for dry age-related macular degeneration (AMD), a leading cause of blindness in adults over 55.
A growing body of evidence suggests that using infrared light — photobiomodulation ... in yet — and that while the Food and Drug Administration has approved some red-light devices for sale ...
The science of skincare continues to expand, and some of those advances have landed directly in consumers’ hands. Is that a ...
Red light therapy is a form of “photobiomodulation,” which is ... “An in-office device is likely FDA approved and has been evaluated for its effectiveness and safety whereas at-home devices ...
The FDA established its accelerated approval program in 1992 to allow drugs to reach the market quickly for life-threatening ...
The Office of Inspector General reviewed the FDA’s use of accelerated approval for 24 drugs, ultimately finding issues with ...
The review, which was spurred by controversy over the FDA's Aduhelm approval, recommends two main changes in agency ...
An OIG report zeroed in on what it said were three particularly problematic accelerated approvals: Biogen’s Aduhelm, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback